Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-445438

Director acquired 1,428,571 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Third Rock Ventures V, L.P. Director 2026-10-30 Grant or award +238,095 $21.00 $4,999,995 6,518,620 D
Third Rock Ventures V, L.P. Director 2026-10-30 Grant or award +1,190,476 $21.00 $24,999,996 2,159,694 I
Loading xslF345X06/ownership.xml…